We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$335B
AUM Growth
+$21B
Cap. Flow
-$4B
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.52%
Holding
3,670
New
323
Increased
1,420
Reduced
1,524
Closed
323

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.66B
2
BABA icon
Alibaba
BABA
+$881M
3
INTC icon
Intel
INTC
+$783M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$783M
5
LIN icon
Linde
LIN
+$667M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Financials 13%
3 Consumer Discretionary 12.7%
4 Healthcare 12.61%
5 Communication Services 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLDN icon
2851
Willdan Group
WLDN
$1.3B
$1.4M ﹤0.01%
37,086
-2,196
-6% -$84.8K
BYSI icon
2852
BeyondSpring
BYSI
$35.8M
$1.4M ﹤0.01%
133,536
-40,398
-23% -$426K
TG icon
2853
Tredegar Corp
TG
$310M
$1.39M ﹤0.01%
100,868
-16,715
-14% -$252K
ULH icon
2854
Universal Logistics Holdings
ULH
$529M
$1.39M ﹤0.01%
59,479
-2,209
-4% -$55.1K
SFST icon
2855
Southern First Bancshares
SFST
$600M
$1.38M ﹤0.01%
27,011
-278
-1% -$14.4K
DZSI
2856
DELISTED
DZS Inc. Common Stock
DZSI
$1.38M ﹤0.01%
66,294
+25,529
+63% +$443K
EMKR
2857
DELISTED
Emcore Corp
EMKR
$1.37M ﹤0.01%
+14,889
New +$1.2M
NRIM icon
2858
Northrim BanCorp
NRIM
$587M
$1.36M ﹤0.01%
126,920
+8,156
+7% +$88.7K
CBAY
2859
DELISTED
Cymabay Therapeutics
CBAY
$1.35M ﹤0.01%
310,887
-49,691
-14% -$220K
CCRD
2860
DELISTED
CoreCard
CCRD
$1.35M ﹤0.01%
42,885
-1,750
-4% -$62.4K
CNBKA
2861
DELISTED
Century Bancorp Inc/Mass
CNBKA
$1.35M ﹤0.01%
11,841
-1,642
-12% -$185K
KNTE
2862
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$1.34M ﹤0.01%
57,743
+8,557
+17% +$218K
FLNA
2863
Filana Therapeutics
FLNA
$48.1M
$1.34M ﹤0.01%
404,459
-73,382
-15% -$3.93M
POWL icon
2864
Powell Industries
POWL
$7.71B
$1.34M ﹤0.01%
129,711
-12,300
-9% -$141K
OLMA icon
2865
Olema Pharmaceuticals
OLMA
$1.05B
$1.34M ﹤0.01%
47,775
+3,579
+8% +$102K
AMNB
2866
DELISTED
American National Bankshares Inc
AMNB
$1.34M ﹤0.01%
42,988
-523
-1% -$17.6K
RES icon
2867
RPC Inc
RES
$1.3B
$1.33M ﹤0.01%
269,808
+31,839
+13% +$172K
NMTR
2868
DELISTED
9 Meters Biopharma
NMTR
$1.33M ﹤0.01%
+60,662
New +$1.49M
ARTNA icon
2869
Artesian Resources
ARTNA
$358M
$1.33M ﹤0.01%
36,246
+1,329
+4% +$53K
UTMD icon
2870
Utah Medical Products
UTMD
$225M
$1.33M ﹤0.01%
15,649
+1,697
+12% +$147K
FLNT
2871
Fluent
FLNT
$120M
$1.33M ﹤0.01%
75,527
-4,489
-6% -$88.6K
STGW icon
2872
Stagwell
STGW
$2.24B
$1.33M ﹤0.01%
+227,101
New +$1.06M
PCSB
2873
DELISTED
PCSB Financial Corporation
PCSB
$1.33M ﹤0.01%
72,953
-17,625
-19% -$315K
MCRB icon
2874
Seres Therapeutics
MCRB
$48.4M
$1.31M ﹤0.01%
14,168
+3,093
+28% +$1.31M
BRBS icon
2875
Blue Ridge Bankshares
BRBS
$332M
$1.31M ﹤0.01%
+74,884
New +$1.23M

Similar funds

Nuveen's Q2 2021 Portfolio in Review

As of Q2 2021, Nuveen held 3,670 positions worth $335B, up 6.7% from $314B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2021 filing shows 323 new, 1,420 increased, 1,524 reduced and 323 closed positions. Its largest new stake was UiPath: 2,457,331 shares worth $167M. The largest sale was Apple, an estimated $1.66B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2021 buy was UiPath: 2,457,331 shares worth $167M.
  • Nuveen added most to Wells Fargo in Q2 2021, an estimated $512M increase.
  • Nuveen's biggest Q2 2021 reduction was Apple, cutting an estimated $1.66B.
  • Nuveen fully exited SolarEdge in Q2 2021, selling an estimated $66M.
  • Nuveen's ten largest holdings make up 22% of its $335B portfolio in Q2 2021.
  • Nuveen opened 323 new positions and closed 323 in Q2 2021.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $335B.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.